Viewing Study NCT02677805


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2026-02-21 @ 12:17 PM
Study NCT ID: NCT02677805
Status: COMPLETED
Last Update Posted: 2025-03-19
First Post: 2016-02-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
Sponsor: Croma-Pharma GmbH
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CPH-302-201030
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators